Cargando…

Inside the Noonan “universe”: Literature review on growth, GH/IGF axis and rhGH treatment: Facts and concerns

Noonan syndrome (NS) is a disorder characterized by a typical facial gestalt, congenital heart defects, variable cognitive deficits, skeletal defects, and short stature. NS is caused by germline pathogenic variants in genes coding proteins with a role in the RAS/mitogen-activated protein kinase sign...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stagi, Stefano, Ferrari, Vittorio, Ferrari, Marta, Priolo, Manuela, Tartaglia, Marco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9434367/ https://www.ncbi.nlm.nih.gov/pubmed/36060964 http://dx.doi.org/10.3389/fendo.2022.951331

Ejemplares similares

Noonan syndrome: rhGH treatment and PTPN11 mutation
por: Wu, Xian, et al.
Publicado: (2023)

Diagnosis of Idiopathic GHD in Children Based on Response to rhGH Treatment: The Importance of GH Provocative Tests and IGF-1
por: Felício, João Soares, et al.
Publicado: (2019)

GH Resistance Is a Component of Idiopathic Short Stature: Implications for rhGH Therapy
por: Savage, Martin O., et al.
Publicado: (2021)

Safety of Pediatric rhGH Therapy: An Overview and the Need for Long-Term Surveillance
por: Cianfarani, Stefano
Publicado: (2021)

Clinical Characteristics of Short-Stature Patients With Collagen Gene Mutation and the Therapeutic Response to rhGH
por: Chen, Meiping, et al.
Publicado: (2022)

Corrigendum: Clinical Characteristics of Short-Stature Patients With Collagen Gene Mutation and the Therapeutic Response to rhGH
por: Chen, Meiping, et al.
Publicado: (2022)

Corroboration of Height Velocity Prediction Markers for rhGH With an Oral GH Secretagogue Treatment in Children With GHD
por: Blum, Werner F, et al.
Publicado: (2021)

SUN-250 Natural History of Growth in Patients with SHOX Gene Haploinsufficiency and Impact of Treatment with rhGH in Adult Height
por: Menezes De Andrade, Nathalia, et al.
Publicado: (2019)

GH Responsiveness in Children With Noonan Syndrome Compared to Turner Syndrome
por: Dahlgren, Jovanna, et al.
Publicado: (2021)

Decreased Thyroxine Levels during rhGH Therapy in Children with Growth Hormone Deficiency
por: Witkowska-Sędek, Ewelina, et al.
Publicado: (2021)

Phase 2 Randomized, Placebo-Controlled Clinical Trial of Recombinant Human Growth Hormone (rhGH) During Rehabilitation From Traumatic Brain Injury
por: Dubiel, Rosemary, et al.
Publicado: (2018)

Novel pathogenic NPR2 variants in short stature patients and the therapeutic response to rhGH
por: Chen, Hong, et al.
Publicado: (2023)

The Efficacy of GnRHa Alone or in Combination with rhGH for the Treatment of Chinese Children with Central Precocious Puberty
por: Wang, Mengjie, et al.
Publicado: (2016)

The phenotype and rhGH treatment response of ring Chromosome 15 Syndrome: Case report and literature review
por: Chen, Meiping, et al.
Publicado: (2021)

THU178 Predicted Adult Height Outcomes And Relation To Final Adult Height In Children With Isolated Idiopathic Growth Hormone Deficiency Treated With rhGH Therapy
por: Duong, Binh (Bailey), et al.
Publicado: (2023)

Responses to growth hormone (GH) therapy in short children with normal GH secretion and no bone age delay: an analysis of potential factors affecting their response to rhGH therapy. A controlled study
por: Soliman, Ashraf T, et al.
Publicado: (2019)

Analysis of the Influence of High-Dose rhGH Therapy on Serum Vitamin D and IGF-1 Levels in School-Age Children with Idiopathic Short Stature
por: Li, Juan, et al.
Publicado: (2021)

The Multiple Faces of the GH/IGF Axis
por: Chesnokova, Vera
Publicado: (2022)

Small molecules to regulate the GH/IGF1 axis by inhibiting the growth hormone receptor synthesis
por: van der Velden, Lieke M., et al.
Publicado: (2022)

PSAT108 Impact of recombinant human growth hormone (rhGH) on skeletal muscle strength, power, endurance and agility in prepubertal boys with significant short stature: preliminary results
por: Welch, Lurah, et al.
Publicado: (2022)

Retracted: Analysis of the Influence of High-Dose rhGH Therapy on Serum Vitamin D and IGF-1 Levels in School-Age Children with Idiopathic Short Stature
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Ten years with biosimilar rhGH in clinical practice in Sweden – experience from the prospective PATRO children and adult studies
por: Lundberg, Elena, et al.
Publicado: (2020)

SUN-254 A Long-Term, Phase IV Study of Omnitrope®, a Recombinant Human Growth Hormone (rhGH), in Short Children Born Small for Gestational Age (SGA)
por: Schwarz, Hans-Peter, et al.
Publicado: (2019)

THU166 A Minimum Data Set For The Monitoring Of Recombinant Human Growth Hormone (rhGH) Therapy In Children With Growth Hormone Deficiency (GHD)—A GloBE-Reg Initiative
por: Chen, Suet Ching, et al.
Publicado: (2023)

Physician experience with once-weekly somatrogon versus once-daily rhGH regimen in pediatric patients with growth hormone deficiency: a cross-sectional survey of physicians from the global phase 3 study
por: Gomez, Roy, et al.
Publicado: (2023)

Investigating whether serum IGF-1 and IGFBP-3 levels reflect the height outcome in prepubertal children upon rhGH therapy: LG growth study database
por: Kim, Minsun, et al.
Publicado: (2021)

The GH/IGF-1 Axis and Heart Failure
por: Castellano, Graziella, et al.
Publicado: (2009)

The GH-IGF-1 Axis in Circadian Rhythm
por: Wang, Weihao, et al.
Publicado: (2021)

Diagnosis of GH Deficiency Without GH Stimulation Tests
por: Ibba, Anastasia, et al.
Publicado: (2022)

Effects of recombinant human growth hormone (rhGH) administration on body composition and cardiovascular risk factors in obese adolescent girls
por: Slattery, Meghan, et al.
Publicado: (2014)

mPEG-PLA and PLA-PEG-PLA nanoparticles as new carriers for delivery of recombinant human Growth Hormone (rhGH)
por: Ghasemi, Rohollah, et al.
Publicado: (2018)

Practical tools to identify short children born small-for-gestational-age eligible for rhGH treatment according to Italian regulation
por: Tornese, Gianluca, et al.
Publicado: (2019)

Cysteamine improves growth and the GH/IGF axis in gilthead sea bream (Sparus aurata): in vivo and in vitro approaches
por: Sánchez-Moya, Albert, et al.
Publicado: (2023)

GH Replacement in the Elderly: Is It Worth It?
por: Ricci Bitti, Silvia, et al.
Publicado: (2021)

GH and IGF System: The Regulatory Role of miRNAs and lncRNAs in Cancer
por: Catellani, Cecilia, et al.
Publicado: (2021)

The crosstalk between FGF21 and GH leads to weakened GH receptor signaling and IGF1 expression and is associated with growth failure in very preterm infants
por: Mistry, Jayna N., et al.
Publicado: (2023)

Neurotrophic and Neuroregenerative Effects of GH/IGF1
por: Bianchi, Vittorio Emanuele, et al.
Publicado: (2017)

Update on new GH-IGF axis genetic defects
por: Vasques, Gabriela A., et al.
Publicado: (2019)

Postoperative GH and Degree of Reduction in IGF-1 Predicts Postoperative Hormonal Remission in Acromegaly
por: Cardinal, Tyler, et al.
Publicado: (2021)

Author Correction: mPEG-PLA and PLA-PEG-PLA nanoparticles as new carriers for delivery of recombinant human Growth Hormone (rhGH)
por: Ghasemi, Rohollah, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_n4ft64slav6vqbcac3f5d3jf6f